Posted on 11/12/20
Protara Therapeutics Announces Third Quarter 2020 Financial Results and Business Overview
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare . . .
Posted on 11/12/20
Pfizer's Coronavirus Vaccine Data Is Better Than Meets the Eye
As of Tuesday, there have been more than 50.9 million confirmed cases of the novel coronavirus worldwide, and 1.26 million deaths. In the U.S. alone, researchers . . .
Posted on 11/12/20
Could Pfizer Be a Millionaire-Maker Stock?
When Albert Bourla assumed the role of chairman and chief executive officer at Pfizer (NYSE:PFE) at the beginning of 2019, he moved quickly to create a . . .
Posted on 11/10/20
Coronavirus Vaccine Candidate From Pfizer and BioNTech Leaps Over Efficacy Hurdle
Buck up campers, it might all be over soon. On Monday morning, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced success with their coronavirus vaccine candidate, BNT162b2, following . . .
Posted on 11/10/20
Pfizer Vaccine News Pumps Up Oil Prices
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced this morning that their coronavirus vaccine candidate BNT162b2 is showing 90% effectiveness in phase 3 clinical trials. The companies are . . .
Posted on 11/10/20
Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR) today reported its third quarter 2020 financial results, program progress and corporate updates.“During . . .
Posted on 11/10/20
Cara Therapeutics Reports Third Quarter 2020 Financial Results
STAMFORD, Conn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to . . .
Posted on 11/10/20
Abeona Therapeutics Reports Third Quarter Financial Results
NEW YORK and CLEVELAND, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced financial . . .
Posted on 11/10/20
TG Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the third quarter ended September 30, 2020 . . .
Posted on 11/10/20
Fortress Biotech Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO), an innovative revenue-generating company focused on acquiring, developing and commercializing or monetizing promising . . .
Posted on 11/10/20
HealthComp Announces Partnership with New Mountain Capital
FRESNO, Calif. & NEW YORK--(BUSINESS WIRE)--HealthComp Holding Company LLC (“HealthComp” or “the Company”), a leading independent Third Party Administrator (TPA) of healthcare benefits for self-funded employers, . . .
Posted on 11/10/20
Bristol Myers Squibb Prices $7B of Senior Unsecured Notes
NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today announced that it has priced a public offering (the “Offering”) of senior unsecured notes in a combined aggregate principal . . .
Posted on 11/9/20
Biohaven Reports Third Quarter 2020 Financial Results
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial . . .
Posted on 11/9/20
UroGen Pharma Reports Third Quarter 2020 Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced . . .
Posted on 11/9/20
Intercept Pharmaceuticals Reports Third Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides Business Update
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to . . .
Posted on 11/9/20
Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update
NEW YORK and SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small . . .
Posted on 11/9/20
Intra-Cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate Update
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central . . .
Posted on 11/9/20
Homology Medicines Announces $60 Million Equity Investment from Pfizer
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc. (NYSE: PFE) has agreed . . .
Posted on 11/9/20
KBL Merger Corp. IV Acquires 180 Life Sciences
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM), a special purpose acquisition company (SPAC), today announced the successful completion of . . .
Posted on 11/9/20
Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial results . . .
Posted on 11/9/20
Decibel Therapeutics Raises $82M Series D
Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, today announced the closing of an oversubscribed Series . . .
Posted on 11/9/20
Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks
Ten programs are currently involved in phase 3 trials. But Moderna and Pfizer are arguably the closest to earning Emergency Use Authorizations (EUAs) for their vaccine . . .
Posted on 11/8/20
Dr. Joel Buchalter Named Director of Joint Replacement Surgery at Northern Westchester Hospital’s Orthopedic and Spine Institute
Joel S. Buchalter, MD, FAAOS, FACS, an orthopedic surgeon with more than three decades of experience
Posted on 11/6/20
SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update
JERSEY CITY, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to potentially overcome and prevent difficult-to-treat and . . .
Posted on 11/6/20
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
BEDMINSTER, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to . . .
New York
